发明名称 TRIAZOLE DERIVATIVE
摘要 <p>A compound represented by the formula (I) below or a pharmaceutically acceptable salt thereof has an effect of inhibiting binding between SIP and its receptor Edg-1(S1P 1 ), and is useful as a pharmaceutical product. [where A represents a sulfur atom, an oxygen atom, a formula -SO- or a formula -SO 2 -; R 1 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or the like; R 2 represents an alkyl group having 1 to 6 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms or the like; R 3 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; R 4 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, a phenyl group or the like; R 5 represents a hydrogen atom or an alkyl group having 1 to 6 carbon atoms; and R 6 represents an alkyl group having 1 to 6 carbon atoms, a phenyl group or a substituted phenyl group].</p>
申请公布号 EP1798226(A1) 申请公布日期 2007.06.20
申请号 EP20050768756 申请日期 2005.08.04
申请人 TAISHO PHARMACEUTICAL CO., LTD 发明人 ONO, NAOYA;SATO, MASAKAZU;SHIOZAWA, FUMIYASU;YAGI, MAKOTO;YABUUCHI, TETSUYA;TAKAYAMA, TETSUO;KATAKAI, HIRONORI
分类号 C07D249/12;A61K31/4196;A61K31/4439;A61K31/454;A61K31/5377;A61P1/04;A61P9/10;A61P11/06;A61P17/00;A61P17/06;A61P19/02;A61P25/00;A61P25/28;A61P27/02;A61P29/00;A61P35/00;A61P37/00;A61P37/06;A61P37/08;A61P43/00 主分类号 C07D249/12
代理机构 代理人
主权项
地址